Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

SPONSORED

A Timely Intervention: Early Clues to Identify the Patient With PsO at Risk for PsA

04/04/2022

Advertisement

Advertisement

Popular Articles
Sun Protection and the Therapeutic Pipeline: Q&A With Dr Leachman
05/19/2021
Sancy Leachman, MD, PhD, met with The Dermatologist to discuss skin cancer—particularly focusing on melanoma—and other related cutaneous cancers.
Sancy Leachman, MD, PhD, met with The Dermatologist to discuss skin cancer—particularly focusing on melanoma—and other related cutaneous cancers.
Sancy Leachman, MD, PhD, met...
05/19/2021
The Dermatologist
News
Older Adults Experience Low Surgical Treatment Burden and Complications With Basal Cell Carcinoma
06/24/2021

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Older adults who are surgically treated for basal cell carcinoma in the head and neck area experience low surgical treatment burden and complications.
Older adults who are surgically treated for basal cell carcinoma in the head and neck area experience low surgical treatment burden and complications.
Older adults who are surgically...
06/24/2021
The Dermatologist
Hidradenitis Suppurativa: Video Interview With Dr. Joslyn Kirby
SPONSORED
Hidradenitis Suppurativa: Video Interview With Dr Joslyn Kirby
04/04/2022
Dr Joslyn Kirby discusses what dermatologists should know about hidradentitis suppurativa, which can be devastating for patients with the disease.
Dr Joslyn Kirby discusses what dermatologists should know about hidradentitis suppurativa, which can be devastating for patients with the disease.
Dr Joslyn Kirby discusses what...
04/04/2022
Dermatology
psoriasis on arm
Conference Coverage
Favorable Safety Profile of Ixekizumab Through 5 Years, No Yearly Incidence Rate Increases
03/26/2022
Julie Gould
According to a poster at the AAD annual meeting, from the year of exposure among patients, the safety profile of ixekizumab was favorable through year 5 without yearly increases of incidence rates.
According to a poster at the AAD annual meeting, from the year of exposure among patients, the safety profile of ixekizumab was favorable through year 5 without yearly increases of incidence rates.
According to a poster at the AAD...
03/26/2022
The Dermatologist
News
Patients With Psoriasis on Biologic Treatments Are Not More Susceptible to Severe COVID-19
10/05/2022
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to determine whether the biologic treatment of psoriasis increases SARS-CoV-2 infection risk.
Researchers aimed to determine whether the biologic treatment of psoriasis increases SARS-CoV-2 infection risk.
Researchers aimed to determine...
10/05/2022
Dermatology

Advertisement

Advertisement

Sign Up for eNews!

Dermatology Newsletter

Advertisement

Advertisement

Dermatology News

psoriasis
News
Dermoscopy in Psoriasis: Clinical Value
07/24/2024
Dermoscopy has gained significant attention for its utility in evaluating inflammatory skin diseases, such as psoriasis.
Dermoscopy has gained significant attention for its utility in evaluating inflammatory skin diseases, such as psoriasis.
Dermoscopy has gained...
07/24/2024
Dermatology
psoriasis
News
Psoriasis as a Systemic Disease: Evidence and Management
07/09/2024
Researchers explored the pathophysiologic relationship between psoriasis and its common comorbidities.
Researchers explored the pathophysiologic relationship between psoriasis and its common comorbidities.
Researchers explored the...
07/09/2024
Dermatology
psoriasis
News
Cardiovascular Risk Assessment in Psoriasis
06/20/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate...
06/20/2024
Dermatology
psoriasis
News
Nail Psoriasis Association With IL-17
06/07/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate...
06/07/2024
Dermatology
psoriasis
News
Bibliometric Analysis of Metabolomics Trends in Psoriasis
05/13/2024
Jessica Garlewicz, Digital Managing Editor
Researchers conducted a bibliometric analysis of publications on metabolomics in psoriasis from 2011 to 2024.
Researchers conducted a bibliometric analysis of publications on metabolomics in psoriasis from 2011 to 2024.
Researchers conducted a...
05/13/2024
Dermatology
psoriasis
News
Determining the Risk Factors for Joint Damage in Psoriasis
05/01/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to address the need for early detection of psoriatic arthritis in patients with psoriasis.
Researchers aimed to address the need for early detection of psoriatic arthritis in patients with psoriasis.
Researchers aimed to address the...
05/01/2024
Dermatology
psoriasis
News
CD6-ALCAM Polymorphisms Potentially Modulate Psoriasis Risk and Outcomes
04/24/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to investigate the potential association between polymorphisms in CD6 and ALCAM genes and susceptibility to psoriasis vulgaris.
Researchers aimed to investigate the potential association between polymorphisms in CD6 and ALCAM genes and susceptibility to psoriasis vulgaris.
Researchers aimed to investigate...
04/24/2024
Dermatology
psoriasis
News
The Impact of Pediatric Plaque Psoriasis on Children and Caregivers
04/17/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to evaluate the impact of childhood and adolescent chronic plaque psoriasis on the quality of life of parents and caregivers.
Researchers aimed to evaluate the impact of childhood and adolescent chronic plaque psoriasis on the quality of life of parents and caregivers.
Researchers aimed to evaluate...
04/17/2024
Dermatology
psoriasis
News
Causal Relationship Between Serum Metabolites and Psoriasis Risk
03/28/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to investigate the influence of serum metabolites on the risk of psoriasis using Mendelian randomization analysis.
Researchers aimed to investigate the influence of serum metabolites on the risk of psoriasis using Mendelian randomization analysis.
Researchers aimed to investigate...
03/28/2024
Dermatology
psoriasis
News
Utilization of Clinical Trial Imaging for Accurate Psoriasis Area and Severity Index Prediction
03/20/2024
Jessica Garlewicz, Digital Managing Editor
Researchers leverage longitudinal imaging data from the Ultima 2 clinical trial involving patients with psoriasis undergoing treatment.
Researchers leverage longitudinal imaging data from the Ultima 2 clinical trial involving patients with psoriasis undergoing treatment.
Researchers leverage...
03/20/2024
Dermatology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement